Dallah Healthcare Company
4004
Rank in Stocks
#6009
Operating within the Kingdom of Saudi Arabia, Dallah Healthcare Company... Operating within the Kingdom of Saudi Arabia, Dallah Healthcare Company specializes in delivering and managing a comprehensive array of healthcare services and infrastructure. Its core activities encompass the operation, management, outfitting, and growth of hospitals, various medical establishments, polyclinics, residential healthcare complexes, and associated land. Additionally, it supplies essential personnel and ancillary services to both hospitals and medical centers. Beyond direct healthcare provision, Dallah Healthcare is also involved in the production and supply of pharmaceutical, herbal, and cosmetic goods, distributing them to individual pharmacies, health and beauty retailers, hospitals, and government bodies. The firm further extends its expertise to include the oversight and running of hospitals belonging to external entities, alongside offering various supplementary support functions. This encompasses the administration of private hospitals, specialized medical and diagnostic centers, and an analytical laboratory, coupled with the direct provision of medical care. Originally established as Dallah Healthcare Holding Company, the organization officially adopted its current name, Dallah Healthcare Company, in November 2016. Founded in 1994, its corporate headquarters are situated in Riyadh, Saudi Arabia, and it operates as a subsidiary of Dallah Al-Barakah Holding.
Share Price
$15.96
Last synced: 2026-11-11
Market Cap
$1.94B
Change (1 day)
1.44%
Change (1 year)
-59.35%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Dallah Healthcare Company (4004)
Category
Healthcare
EPS for Dallah Healthcare Company (4004)
EPS as of September 2026 TTM: $1.75
According to Dallah Healthcare Company's latest financial reports, its current EPS (TTM) is $1.75. At the end of 2025 the company had an EPS of $1.42, an increase over its 2024 EPS of $1.29.
EPS history for Dallah Healthcare Company from 2011 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $1.75 | 23.08% |
| 2025 | $1.42 | 10.33% |
| 2024 | $1.29 | 30.30% |
| 2023 | $0.99 | 21.60% |
| 2022 | $0.81 | 6.13% |
| 2021 | $0.76 | 153.82% |
| 2020 | $0.30 | -33.14% |
| 2019 | $0.45 | 6.98% |
| 2018 | $0.42 | -51.86% |
| 2017 | $0.87 | 31.22% |
| 2016 | $0.67 | 36.04% |
| 2015 | $0.49 | 12.83% |
| 2014 | $0.43 | 7.16% |
| 2013 | $0.41 | -25.12% |
| 2012 | $0.54 | 12.77% |
| 2011 | $0.48 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $30.27 | 1,631.99% |
US
|
|
| $3.19 | 82.49% |
DE
|
|
| $34.71 | 1,886.04% |
US
|
|
| $1.90 | 8.84% |
SA
|
|
| $0.29 | -83.52% |
CN
|
Questions about Dallah Healthcare Company's earnings per share (EPS)
What is Dallah Healthcare Company's earnings per share (EPS)?
Dallah Healthcare Company's earnings per share (EPS) over the last twelve months is $1.75, as of Sep 2026.
What was Dallah Healthcare Company's earnings per share (EPS) in 2025?
In 2025, Dallah Healthcare Company's earnings per share (EPS) was $1.42, 10.08% more than in 2024 ($1.29).
How has Dallah Healthcare Company's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Dallah Healthcare Company's earnings per share (EPS) went from $0.30 to $1.42, an average growth of 36.47% a year.
How does Dallah Healthcare Company's earnings per share (EPS) compare with similar companies?
Dallah Healthcare Company's earnings per share (EPS) ($1.75) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Tenet Healthcare Corporation, with $34.71.